Clinical trials
Pediatrics clinical trials
Below are recruiting pediatrics clinical trials, each written for real people, not researchers. We’re tracking 1,359 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06975046Recruiting
Voice measurements in children with normal and abnormal voices
This study measures sounds and airflow during voice tasks to understand how the voice works in healthy children and adults, and in children with voice disorders. It may help researchers improve treatments for voice problems.
Iowa City, IowaAges 4–65 - NCT06982066Recruiting
Helping Young Cancer Patients Talk with Their Care Team
This study works with teens and young adults (ages 15–25) who have cancer and are currently in treatment. It tests a way to help you talk better with your doctors and nurses about your care, so they can understand your needs and preferences more clearly.
Hartford, ConnecticutAges 15–25 - NCT06972147Recruiting
Food-induced esophagus symptoms in kids with EoE
This study looks at how often children with eosinophilic esophagitis (a type of food allergy causing esophagus swelling) have immediate symptoms after eating certain foods. It may help doctors better understand and manage the condition.
AngersAges 6–17 - NCT06967675Recruiting
Blood flow monitoring in children under low-flow anesthesia
This trial tests whether a device that measures skin blood flow can help monitor children safely during low-flow anesthesia. It is for children aged 2–12 having non-emergency surgery lasting 1–6 hours.
Istanbul, Merkez MahallesiAges 2–12 - NCT06972420Recruiting
Reducing anxiety for children before surgery
This study tests a way to help children aged 5-12 feel less anxious before surgery. If successful, it could make the start of anesthesia calmer and more comfortable for your child.
MarseilleAges 5–12 - NCT06969235Recruiting
Family weight loss program for teens
This study tests a family-based weight loss program for teens ages 13-17 who have overweight or obesity. It looks at how thinking skills (like planning and focus) affect the program's success.
Columbia, MissouriAges 13–17 - NCT06953869RecruitingPhase 3
Testing a sleep medicine for children with insomnia
This study tests if the drug tasimelteon helps children with insomnia sleep better compared to a placebo (a pill with no medicine). It is for children aged 2 to 17 who have been diagnosed with insomnia that is not caused by another medicine.
Dothan, AlabamaAges 2–17 - NCT05253495RecruitingPhase 2
Targeted immunotherapy added to chemotherapy and radiation for lymphoma
This Phase 2 trial tests whether adding targeted immunotherapy to standard chemotherapy and radiation can improve outcomes in children with certain types of lymphoma. It may help the immune system work better against cancer.
Birmingham, AlabamaAges 3–39 - NCT06939322Recruiting
Long-term monitoring app for childhood cancer survivors
This trial tests whether a special software (LOG-AFTER) helps people who had cancer before age 25 keep up with long-term screenings. It aims to make follow-up care easier and more consistent.
Angers, Maine Et LoireAges 15 years+ - NCT06934967RecruitingPhase 3
Iptacopan study for children with PNH
This trial tests an oral medication, iptacopan, for children with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood condition. It aims to see how well the drug works in kids who have not tried anti-C5 therapy or who are switching from it.
Atlanta, GeorgiaAges 2–18 - NCT06941272RecruitingPhase 1/Phase 2
Study of patritumab deruxtecan for children with hard-to-treat solid tumors
This trial tests a new drug, patritumab deruxtecan, in children and adolescents whose rhabdomyosarcoma or hepatoblastoma has returned or not responded to at least one prior treatment. The goal is to see if the drug can shrink tumors or stop them from growing.
Los Angeles, CaliforniaAges 1 month–17 years - NCT06940232Recruiting
Blood test study for traumatic brain injury in kids
This study is testing whether a blood test can detect traumatic brain injury (TBI) in children. If successful, it could offer a quicker, less invasive way to diagnose concussions and other head injuries, reducing the need for CT scans or MRIs.
Omaha, NebraskaAges Up to 17 years - NCT06941389Recruiting
Comparing stem cell transplant vs standard therapy for sickle cell disease
This study compares two treatment approaches for children with sickle cell anemia: a stem cell transplant from a matched family donor versus continuing regular disease-modifying medicines. It aims to see which treatment works better over time.
Birmingham, AlabamaAges 3–20 - NCT06938542Enrolling by invitation
Palliative care needs for kids with rare diseases
This study asks children with rare diseases and their families about what kind of palliative care (comfort and support) they need. It aims to understand how to better help families through their child's illness.
Washington D.C., District of ColumbiaAges 1–99 - NCT06934655RecruitingPhase 3
Starting semaglutide again after weight-loss surgery in teens
This trial tests if restarting semaglutide (a weekly injection for weight loss) soon after sleeve gastrectomy helps teens with severe obesity keep losing weight. It is for patients who were already taking semaglutide before their surgery.
Los Angeles, CaliforniaAges 12–18 - NCT06013618RecruitingPhase 2
Naxitamab for high-risk or relapsed neuroblastoma in children
This trial tests a targeted antibody called naxitamab (hu3F8) for children with high-risk neuroblastoma that has come back or is hard to treat. It aims to see if this therapy can help shrink or control the cancer with an acceptable safety profile.
Guangzhou, GuangdongAges 1 year+ - NCT06927193Recruiting
Pain relief for kids in the emergency room
This trial looks back at how well nerve blocks work for children who received them in the emergency department. If your child had a nerve block during an ER visit from 2023 to 2025, this study may include their experience.
HaderaAges Up to 18 years - NCT06928909Recruiting
Leukemia treatment study for children with AML
This study tests a treatment plan for children under 18 with a new diagnosis of acute myeloid leukemia (AML). It aims to provide effective therapy based on standard guidelines, and may include children with certain blood or bone marrow findings even if tests are limited.
Lilongwe, LilongweAges Up to 18 years - NCT06931613Enrolling by invitationPhase 2
STEM CELL TRANSPLANT FOR HODGKIN LYMPHOMA AFTER NIVOLUMAB
This trial tests a stem cell transplant using your own cells for children and teens with Hodgkin lymphoma that has come back or not gotten better after multiple treatments. It involves using a medicine called nivolumab before the transplant to help your body fight the cancer.
MoscowAges 2–18 - NCT06923865Enrolling by invitation
Exercise program for overweight teens
This trial tests whether a supervised exercise program can improve movement skills and motivation in overweight adolescents. It is designed for teens who struggle with physical activity but are otherwise healthy.
BaselAges 12–14 - NCT06926751RecruitingPhase 2
Preventing low white blood cell counts in kids with solid tumors
This trial compares two drugs (Telpegfilgrastim and Filgrastim) to help prevent dangerously low white blood cell counts after chemotherapy in children and young adults with solid tumors. It's for patients who have already had this problem in a previous chemo round.
BeijingAges 6–24 - NCT06927440Enrolling by invitation
Registry for children with severe heart failure in China
This study is creating a registry to learn more about children with advanced heart failure. It will help doctors understand who can benefit from treatments like medicine, devices, or transplants.
Shanghai, Shanghai MunicipalityAges Up to 18 years - NCT06930170Recruiting
Cochlear implant for children with hearing loss in one ear
This trial tests whether a cochlear implant helps children aged 4 to 6 years who have hearing loss in only one ear (or one ear with severe loss and the other with mild loss) improve their hearing and communication. The device is surgically placed in the ear with worse hearing.
ParisAges 4–6 - NCT06900777Recruiting
Comparing two treatments for rapidly spreading vitiligo in children
This trial compares two medicines—oral tacrolimus and dexamethasone micro-pulse therapy—in children aged 4 to 12 whose vitiligo is spreading quickly. The goal is to see which treatment works better to stop the spread and help color return to the skin.
Xi'an, ShaanxiAges 4–12
Hear when a new Pediatrics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pediatrics?
- Yes. Clin2 currently lists 1,359 recruiting pediatrics studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pediatrics trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pediatrics trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.